Tag Archives: treatment

FDA Approves Trodelvy, the First Treatment for Metastatic Triple-Negative Breast Cancer Shown to Improve Progression-Free Survival and Overall Survival

FOSTER CITY, Calif.–(BUSINESS WIRE)–Apr. 7, 2021– Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has granted full approval to Trodelvy® (sacituzumab govitecan-hziy) for adult patients with unresectable locally advanced or metastatic triple-negative breast cancer (TNBC) who have received two or more prior systemic therapies, at least one of them for metastatic disease. The… Read More »

Is There Treatment for Varicose Veins?

What Are Varicose Veins, and What Causes Them? Blood is meant to travel from your heart throughout your body via your veins. These veins have valves that open to let blood flow past and close off behind it. When these valves aren’t working correctly or become weak, blood is then backed up around the vein… Read More »

FDA Approves Qelbree (viloxazine) for the Treatment of ADHD

FDA Approves Qelbree (viloxazine) for the Treatment of ADHD ROCKVILLE, Md., April 02, 2021 (GLOBE NEWSWIRE) — Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced that the U.S. Food and Drug Administration (FDA) approved Qelbree (viloxazine extended-release capsules) for the treatment of attention-deficit hyperactivity… Read More »

FDA Approves Zegalogue (dasiglucagon) Injection for the Treatment of Severe Hypoglycemia in People with Diabetes

FDA Approves Zegalogue (dasiglucagon) Injection for the Treatment of Severe Hypoglycemia in People with Diabetes Copenhagen, DK and Boston, MA, U.S. March 22, 2021 – Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078,) a biotechnology company aspiring to deliver innovation with novel peptide therapeutics, announced today that the U.S. Food and Drug Administration (FDA) has approved Zegalogue® (dasiglucagon)… Read More »

Top 5 stories on injectable HIV treatment and prevention from CROI 2021

One of the most important HIV conferences of the year, the Conference on Retroviruses and Opportunistic Infections (CROI 2021) took place earlier this month. A key theme was the development of injectable medications for use as HIV treatment or as pre-exposure prophylaxis (PrEP). One expert said that the next decade promises to be an era… Read More »

São Paulo patient experiences apparent viral rebound a year and a half after stopping HIV treatment

A Brazilian man who last summer had no evidence of remaining HIV after more than 15 months off antiretroviral therapy once again had detectable viral load a few months later, according to a report last week at the virtual Conference on Retroviruses and Opportunistic Infections (CROI). Work is underway to determine whether he experienced viral… Read More »